urothelial carcinoma
FDA Approves Opdivo Combination for Unresectable or Metastatic Urothelial Carcinoma
The FDA approved nivolumab (Opdivo, Bristol Myers Squibb) in combination with cisplatin and gemcitabine for ...
MARCH 7, 2024
Balversa Approved for Locally Advanced or Metastatic Urothelial Carcinoma
The FDA approved erdafitinib (Balversa, Janssen Biotech) for adult patients with locally advanced or metastatic ...
JANUARY 22, 2024
FDA Approves Padcev with Keytruda for Locally Advanced or Metastatic Urothelial Cancer
The FDA approved enfortumab vedotin-ejfv (Padcev, Astellas Pharma) in combination with pembrolizumab (Keytruda, ...
DECEMBER 17, 2023
Study Provides New First-Line Standard for Advanced Bladder Cancer
Clinicians have a new first-line standard for advanced bladder cancer, according to an international phase 3 study, ...
NOVEMBER 7, 2023
Padcev With Keytruda Approved for Locally Advanced or Metastatic Urothelial Carcinoma
The FDA gave accelerated approval to enfortumab vedotin-ejfv (Padcev, Astellas Pharma) with pembrolizumab ...
APRIL 5, 2023
Maintenance Rucaparib After Chemo Extends PFS in Some Metastatic Urothelial Cancers
Maintenance therapy with the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib following platinum-based ...
APRIL 18, 2022
FDA Expands Opdivo Label to Include Adjuvant Treatment of UC
The FDA approved nivolumab (Opdivo, Bristol Myers Squibb) for the adjuvant treatment of patients with urothelial ...
AUGUST 27, 2021
Padcev Granted Regular Approval for Locally Advanced or Metastatic UC
The FDA approved enfortumab vedotin-ejfv (Padcev, Astellas Pharma) to treat some adults with locally advanced or ...
JULY 19, 2021
Bavencio Receives New Indication for Maintenance in Advanced Urothelial Carcinoma
The FDA granted a new indication for avelumab for the maintenance treatment of patients with locally advanced or ...
JULY 6, 2020
Erdafitinib Shows Promise in Advanced Bladder Cancer
The fibroblast growth factor receptor inhibitor erdafitinib (Balversa, Janssen) showed promising antitumor activity ...
AUGUST 23, 2019
FDA Approves First FGFR Kinase Inhibitor for Advanced Bladder Ca
The FDA granted accelerated approval to erdafitinib (Balversa, Janssen) for the treatment of adults with locally ...
APRIL 17, 2019
Keytruda Approved for Urothelial Cancer
The drug was granted approval for the treatment of patients with locally advanced or metastatic urothelial ...
MAY 18, 2017